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Summary.-Equimolar concentrations of cysteamine and reduced glutathione pro-
tected against the cytotoxicity of5mm misonidazole (MISO), whereas 5mM ascorbate
enhanced its toxicity to hypoxic CHO and HeLa cells in vitro. Protection (reappear-
ance of a shoulder region) could also be seen when cysteamine was added at later
incubation times. These changes in toxicity were accompanied by changes in drug
metabolism, as evidenced by radiochromatograms of cell extracts obtained after
treatment with 14C-labelled MISO. In contrast, radiochromatograms obtained from
cells treated with toxic levels of MISO (75mm) under aerobic conditions indicated no
drug metabolism. Both toxicity and drug metabolism could be immediately halted
by introducing 02 during hypoxic exposures to MISO. These observations are dis-
cussed in terms of a possible model for the metabolism-mediated toxicity of MISO
and the roles which sulphydryls and 02 may play.
RAPIDLY GROWING tumour tissue with
poor vascularization may contain regions
of radioresistant but viable hypoxic cells.
The possibility that hypoxic cells may be
a limiting factor in achieving local tumour
control in some radiotherapy regimes has
led to the development of a class of
compounds which can sensitize hypoxic
tumour cells to ionizing radiation damage.
Misonidazole (1-(2-nitro-1-imidazolyl)-3-
methoxy-2-propanol, MISO) an electron-
affinic nitroheterocyclic radiosensitizer, is
currently undergoing clinical investigation
(Dische, 1978; Urtasun et al., 1977;
Wasserman et at., 1979). Because of an
additional preferential cytotoxicity to-
ward hypoxic cells in the absence ofradia-
tion (Hall & Roizin-Towle, 1975; Moore
et al., 1976) a chemotherapeutic use ofthis
compound in the treatment of non-
cycling hypoxic tumour cells can also be
envisaged. This toxicity is dependent upon
temperature (Hall & Biaglow, 1977;
Stratford & Adams, 1977), 02 concentra-
tion (Stratford, 1978; Taylor & Rauth,
1978) and cell line (Palcic & Skarsgard,
1978; Taylor & Rauth, 1978) and appears
to involve an oxygen-sensitive reductive
metabolism of the drug (Varghese et al.,
1976; Wong et al., 1978) to what may be
the ultimate cytotoxic agent(s). Still other
factors influencing the cytotoxicity of
some nitroheterocyclic radiosensitizers
may be of clinical importance. Among
these factors are tissue enzyme levels,
which may enhance drug metabolism, and
the presence of certain cellular reducing
species. Ascorbate (ASC) has been shown
to increase the cytotoxicity of MISO to-
ward hypoxic Chinese hamster ovary
(CHO) cells (Josephy et al., 1978) while
cysteamine (MEA), a radical scavenger
and radioprotector, has been shown to
protect against its cytotoxic effects (Hall
et al., 1977). This raises the question
whether or not the ASC-enhanced toxicity
of MISO (Josephy et al., 1978; Koch et al.,
1979) is mediated by an increased forma-
tion oftoxic drug metabolites. Evidence is
presented in this paper that ASC does
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promote the reduction of MISO, leading
to a greater accumulation ofdrug metabo-
lites in the cell. Also the effects of MEA
and reduced glutathione (GxSH) on the
metabolism of MISO have been investi-
gated. These results are discussed in terms
of a possible model implicating sulphydryl
(R-SH) depletion in the hypoxic cell
toxicity ofMISO.
MATERIALS AND METHODS
Colony-forming assays were carried out as
described previously (Taylor & Rauth, 1978)
to assess the toxicity of MISO under hypoxic
conditions in the presence of the following
reducing agents: cysteamine HCI, reduced
glutathione (Sigma Chemical Co., St Louis,
Mo) and ascorbate (Gibco Canada, Burling-
ton, Ont.). MISO was a gift from C. E.
Smithen (Roche Products, Welwyn Garden
City, England). Appropriate concentrations
of all drugs were freshly prepared in ot-
medium (Stanners et al., 1971) plus 10%
foetal calf serum (FCS, Flow Laboratories,
Rockville, Md) placed immediately under a
N2 atmosphere (containing 5%o CO2 and
<10/106 02; Gas Dynamics Ltd, Toronto,
Ont.) and allowed 45 min to deoxygenate
before the addition of the cells. Precautions
were taken to prevent oxidation of the ASC,
MEA and GSH. Exponential-phase CHO or
HeLa cells were concentrated at 10 times the
desired final cell density (2-5x 106/ml),
loaded into lml syringes, and allowed
approximately 5 min to respire away the 02
before injection into the deoxygenated drug
suspensions (9 ml) at zero time. All incuba-
tions were carried out at 37°C, using stirred
suspensions (10 ml total volume) under a
continuous-flow N2 atmosphere. Small vol-
umes (25-125 ,lA) of a 69 g/l sodium bi-
carbonate solution were added to the vials
containing MEA, GSH or ASC, since these
agents lowered the pH below that measured
(pH=7.3) for a-medium+10% FCS in
equilibrium with 5%o CO2 without cells.
Oxygen measurements were made using a
Yellow Springs oxygen probe (Yellow Springs
Instrument Co., Yellow Springs, Ohio) and a
voltage supply and current amplifier based on
the design of Koch & Kruuv (1972).
Descending paper chromatography pro-
cedures as described previously by Taylor &
Rauth (1978) were used to study the distribu-
tion of metabolites in the water-soluble
fraction of 5 x 107 CHO cells or 3 x 107 HeLa
cells (0.1 ml packed cells) after exposures to
14C-labelled MISO (synthesized by Dr A. J.
Varghese; Varghese et al., 1976) and various
reducing agents. Briefly, cells were removed
from the incubation medium by centrifuga-
tion in a 10ml Constable tube, homogenized
in 1 ml distilled water and the homogenate
centtifuged at 105,000 g for 1 h. The clear
supernatant was spotted on Whatman No. 3
MM chromatography paper (Fisher Scien-
tific Co. Ltd, Toronto, Ont.) and developed
for 16 h in water-saturated 2-butanol. The
chromatograms were cut in lcm strips and
the distribution of radioactivity determined
by liquid scintillation counting techniques.
In preliminary experiments each strip of the
cell chromatograms was eluted in 2 ml dis-
tilled water before counting and the optical
density of the eluate measured at 325 nm to
determine whether the NO2 group of MISO
was still intact.
RESULTS
Fig. 1 shows the survival of hypoxic
CHO cells exposed to 5mM MISO in the
presence of equimolar concentrations of
ASC, GSH and MEA. The results in the
presence of ASC indicate an enhancement
of the cytotoxic effects of MISO whereas
the 2 sulphydryl compounds appear to
reduce this toxicity, MEA being the more
effective. These effects are seen mainly as
modifications ofthe shoulder region ofthe
survival curves (Fig. 1). The survival of
cells treated with both ASC and MEA in
combination with MISO (data not shown)
looked very similar to the curve for MISO
+GSH in Fig. 1, indicating a slight pre-
dominance of the protective effect of the
SH-containing compound.
The results obtained when HeLa cells
were exposed to 5mM MISO in the presence
of equimolar concentrations of ASC or
MEA are shown in Fig. 2. Again, there is
an enhancement of the cytotoxicity of
MISO by ASC and protection by MEA. In
addition, a survival curve obtained for
cells treated with ASC and MEA in com-
bination with MISO is shown (Fig. 2). As
was seen for CHO cells, the protective
effect of the sulphydryl compound pre-
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FIG. I.-Tlie survi,.-al of CHO cells (5 x 106/
ml) as a fLinction of time under liypoxic
conditions in the presence of 5mm concen-
trations of the following agents: ASC (Ej);
MEA (x); GSH (A); MISO (0) miso
+ASC (0); MISO+MEA (1); MISO+
GSH (,&); Control(0).Multiple timepoints
represent data from 2 independent experi-
ments. The MISO (0) survival curve
points indicate the average values from 3
experiments. A representative error bar
indicates the standard error of the mean.
dominates. As seen earlier (Taylor &
Rauth, 1978) the results here indicate that
the absolute sensitivity of HeLa cells to
MISO is greater than that of CHO cells
(Fig. I v8Fig. 2).
The results of drug-metabolism studies
parallel with the above toxicity studies
are shown in Fig. 3. Panels A-D represent
the distribution of metabolites in the
water-soluble fraction of 5 x 107 CHO cells
after a 5h hypoxic incubation with [14C]_
MISO alone and in combination with
ASC. GSH or MEA. Similarly, Panels E-G
represent the distribution of activity in
the soluble fraction of 3 x 107 HeLa cells
after a 2-5h treatment with [14C]-MISO
alone and in combination with ASC or
MEA. Unaltered MISO, which has an RF
value of 0-84, appears in all chromato-
-5 K).
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Mours
FiG. 2.-The survival of HeLa cells (3 x 106/
ml.) as a function of time un(ler hypoxic
conditions in the presence of 5mAi concen-
trations of the following agents: ASC (F.);
MEA (x); MISO (0); AIISO+ASC
_M1SO+A1EA -.NIISO+ASC+MEA
(A); Control (C)).
grams in this paper at a level consistent
with its remaining in equilibrium with the
extracellular concentration (Taylor &
Rauth, 1978). In addition, there are 3
other major areas where counts accumu-
late (Figs 3A and E). All of these regions
appear to contain nitro-reduced metabo-
lites on the basis of the absence of the
characteristic absorption at 325 nm, due
to the presence of the N02 group on the
imidazole ring of MISO, when the optical
density of the eluate from these areas was
measured. The IOW RF products, including
the doublepeak at RF < O- 15 and thepeak
at RF
= 0-15-0-3, may be conjugated with
cell molecules, since it has been shown that
nitro-reduced metabolites can bind to
protein (Varghese & Whitmore, 1980) and
appear to react with non-protein thiols
(Varnes et al., 1980). The material in the
RF=0-4-0-6 region contains an aminoMODIFIERS OF MISONIDAZOLE METABOLISM
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FIG. 3. The clistribution of 14C-activity in
the water-soluble fraction of 5 x 107 CHO
cells after a 5h hypoxic incubation (A-D)
or 3 x 107 HeLa cells after a 2-5h incuba-
tion (E-G) in the presence of 5mM [14C]-
MISO alone (A and E) or in combination
with 5mM ASC (B and F), MEA (C and
G) or GSH (D).
derivative of MISO (Varghese et al., 1976
and personal communication). The top 2
panels also reflect the differences in the
rate of drug metabolism noted earlier for
these 2 cell lines (Taylor & Rauth, 1978).
Panels B and F of Fig. 3 indicate the
presence of the same peaks when cells are
incubated with MISO +ASC. The in-
creased quantity of metabolites here sug-
gests that the ASC-enhanced toxicity of
MISO is accompanied by an increased rate
of drug metabolism. Panels C and G of
Fig. 3 show the distribution when incuba-
tions are carried out in the presence of
5mM MEA. In contradiction to the most
obvious prediction of decreased metabo-
lism with decreased toxicity, a large in-
crease is noted again in the quantity of
nitro-reduced metabolites (no absorption
at 325 nm) as well as the appearance of at
least one new metabolite in the RF =
0415-0-4 region and another at RF=06.
The distribution obtained in the presence
of the less effective protective agent, GSH
(Fig. 3D) is also characterized by an in-
crease in the total quantity of nitro-
reduced metabolites and the appearance
of at least one new metabolite in the
RF= 015-0-4 region, though the total
activity in the RF=0O4-0 6 region is con-
siderably less than what is seen in CHO
cells treated with MISO alone (Fig. 3A).
The variations in the peak RF values
between the 2 experiments, represented
by the right and left side of Fig. 3, are of
the order typically seen (± 003 RF units)
with this chromatography procedure.
In order to see toxicity toward aerobic
cells within the same time scale as for
hypoxic cells, it is necessary to go to much
higher MISO concentrations. The survival
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FIG. 4. Top: The plating efficiency of CHO
cells (5 x 106/ml) as a function of time
exposed to 75mM MISO under aerobic
conditions (Q) and control (A). Bottom:
The distribution of radioactivity in the
water-soluble fraction of 5 x 107 CHO cells
at 5 h.
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FIG. 5.-The survival of CHO cells (2 x 106/
ml) exposed to 5mM MISO continuously
under hypoxic conditions (*) and in a
split-dose procedure where the cells were
reoxygenated at 41 h by changing the gas
mixture from N2 to air and maintained
under aerobic conditions for 2 h (Oii) or
4 h (A) at 37°C, before monitoring the
subsequent survival under hypoxic condi-
tions again. Multiple points (EO, A) at 4j h
represent the survival at the start and end
of the aerobic incubation and (O)s indicate
the control survival. The time axis includes
only the hypoxic exposure time.
ofCHO cells exposed to 75mM MISO under
aerobic conditions, and the corresponding
5h distribution of metabolites in the
soluble fraction of the cells, are shown in
Fig. 4. In contrast to what is seen under
hypoxic conditions, the aerobic toxicity of
MISO is not accompanied by the appear-
ance of any MISO metabolites.
In an attempt to characterize further
the effects of 02 on drug metabolism, the
split-dose experiments of Stratford (1978)
were repeated. Fig. 5 shows the effects on
cell survival when the exposure of CHO
cells to 5mM MISO under hypoxic condi-
tions is interrupted by the introduction of
02 for 2 and 4 h while maintaining the
cells in suspension at 370C. During this
aerobic exposure time cell survival re-
mains constant. When the cells are ren-
dered hypoxic again, the subsequent
survival curve is characterized by the
reappearance of a shoulder region which
appears to be smaller than the initial
period of resistance. No significant in-
crease in this shoulder region was noted in
going from a 2h to a 4h aerobic incubation.
Measurements of 02 levels, determined
under the same conditions as in this ex-
periment, indicated that the time re-
quired to reoxygenate and deoxygenate
the cells could account for no more than
20 min of the shoulder region seen at 41 h
in Fig. 5.
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FIc. 6.-The survival of CHO cells (2 x 106/
ml) exposed to 5mM MISO under hypoxic
conditions (*) and the hypoxic control
(0). The Ols represent the survival of
hypoxic CHO cells in the presence of 5mM
MISO for a vial to which 100 ,ul of freshly
prepared 450mM MEA was added at 4i h.
This amount gave a final concentration of
5mM MEA withoutsignificantly altering the
MISO concentration already in the vials.
Similarly, the As represent the survival of
hypoxic CHO cells in the presence of 5mM
MISO before and after the addition of 5mM
ASC to the vial at 4j h. In both cases a
small volume of 69 g/l bicarbonate was
added at 4i h to compensate for the in-
crease in acidity due to the addition of
ASC and MEA.
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FIG. 7. The distribution of metabolites in
the water-soluble fraction of cells subjected
to the conditions represented by the sur-
vival data in Figs 5 and 6. Top left: Distri-
bution of radioactivity in cells incubated
for 41 h under hypoxic conditions in 5mM
[14C]-MISO. The other 3 panels represent
distributions obtained for the following
incubation conditions after a 4j h hypoxic
exposure to 5mM [14C]-MISO. Top right:
Reoxygenated and maintained under
aerobic conditions for 2 h at 37°C. Bottom
left: Maintained under aerobic conditions
for 2 h and then made hypoxic again for
another 3 h. Bottom right: Incubated for
an additional 2 h under hypoxic condi-
tions after the addition of 5mm MEA.
Bearing in mind: (i) the regeneration
of the shoulder region in the split-dose
experiment (Fig. 5), (ii) the modifica-
tion of the shoulder region of MISO
survival curves in the presence of ASC,
GSH and MEA (Fig. 1), and (iii) the
possibility that R-SH depletion may play
a role in the shoulder region of these
survival curves, a test of the effects of the
addition ofMEA at the 10-2 survival level
on subsequent cell survival in the presence
of MISO was performed. The results of
this experiment are shown in Fig. 6, where
it appears that the late addition of 5mM
MEA, whilst maintaining the cells in a
hypoxic state, regenerates most of the
increased shoulder region seen when MEA
is present from the start (Fig. 1). No
appreciable change in the MISO survival
curve was noted when 5mM ASC was
added at the 10-2 survival level (Fig. 6).
Fig. 7 shows the distribution of metabo-
lites in CHO cells subjected to the experi-
mental procedures used to obtain the
survival data in Figs 5 and 6. The top left
panel shows the distribution of radio-
activity after a 4-h hypoxic exposure to
5mM MISO (the 4'h point in Figs 5 and 6).
This distribution is qualitatively similar
to that seen in Fig. 3A for a 5h hypoxic
incubation, though there is less activity in
the form of MISO n3gtabolites after this
shorter incubation. The top right panel
shows the distribution of metabolites seen
2 h after the cells are reoxygenated in the
split-dose experiment, and is also repre-
sentative of what is seen after 4 h. This
result suggests that metabolism of the
drug is completely halted during the
aerobic exposure, and that there is no
appreciable leakage of these metabolites
from the cells. The increased activity seen
in the bottom left panel of Fig. 7 is con-
sistent with the resumption of MISO
metabolism when the cells are rendered
hypoxic again and incubated for a further
3 h. The bottom right panel shows the dis-
tribution 2 h after 5mM MEA has been
added to a culture previously exposed to
MISO for 4- h under hypoxic conditions.
There is an increased accumulation of
metabolites as well as the rapid appear-
ance of new metabolite(s) in the RF=
0-15-0-4 region, similar to that previously
noted in Figs 3C and F when MEA was
present during the entire incubation.
DISCUSSION
Enhancement ofthe toxicity ofMISO in
the presence of ASC was seen by Josephy
et al. (1978) and Koch et al. (1979) as well
as in the present investigation (Figs 1
and 2). The effect of 5mM ASC on the sur-
vival of CHO cells (Fig. 1 and Josephy et
al. 1978) appears to be greater than for
HeLa (Fig. 2) or V79 (Koch et al., 1979)
cells, and is characterized by a large
reduction in the shoulder region of the
resulting survival curves. This is in con-
trast to the results of Koch et al. (1979) in
which the influence of ASC was seen
primarily as an increase in the slope ofthe
exponential portion of survival curves
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obtained with monolayer Chinese hamster
V79 cultures. Although their exposure
conditions differed from those used here,
the observed differences may reflect cell-
line variations. The results with HeLa
cells (Fig. 2) more closely parallel the
slope-modifying effect seen with V79 cells,
though the time scale is much reduced for
the more sensitive HeLa cell line.
The protective effects noted here (Figs
1 and 2) for MEA and GSH are consistent
with previous reports (Koch et al. 1979;
Hall et al., 1977). Further comparisons to
distinguish slope- or shoulder-modifying
effects cannot be made, since the above
communications covered a more limited
survival range. Protection was also noted
by Stratford & Gray (1978) when the
R-SH compound D-penicillamine was
used in conjunction with MISO. Their
results indicated an increase in the shoul-
der region ofthe survival curve, analogous
to what was seen here for MEA and GSH
(Fig. 1) accompanied by a small reduction
in slope. In contrast to the protective
effects seen by the above authors, one
group found an increase in toxicity with
GSH (Josephy et al., 1978). Subsequent
studies by this group (Palcic et al., 1980)
indicated pH as a factor determining
whether protection or enhanced toxicity
is seen.
When MEA was used in combination
with ASC, the protective effect of the
R-SH compound predominated. Howell &
Koch (1979) also noted a predominance of
the protective effects of R-SH compounds
when used in combination with ASC. For
both CHO (data not shown, see text) and
HeLa (Fig. 2) cells, the exposure time
required to reach a given survival level
with the combination of agents can be
predicted by the simple addition of the
MEA protection and ASC sensitization
effects. This calculation indicates a rela-
tively larger protective effect for the
combination in HeLa than in CHO cells,
which was seen. These results suggest that
an interaction between ASC and sulphyd-
ryls may be occurring in the cell.
The shoulder reappearance seen in the
split-dose experiment (Fig. 5) is funda-
mentally consistent with what was ob-
served by Stratford (1978) though with a
different cell line, cell density and MISO
concentration. In relation to the initial
shoulder region, the post-aerobic incuba-
tion shoulder region was appreciably
smaller in the present results.
The radiochromatography studies with
[14C]-MISO (Fig. 3) indicate that the
enhanced toxicity with ASC is associated
with a greater rate of accumulation ot
MISO metabolites, and hence a greater
rate of formation of possible cytotoxic
intermediates. While the results obtained
with the R-SH compounds MEA and GSH
also indicate an increased metabolism, the
appearance of new metabolites suggests
additional mechanisms. The MEA result
is consistent with both a radical scaveng-
ing mechanism and the possible formation
of Fe2+-R-SH-MISO complexes, within
which Bahnemann et al. (1978) have indi-
cated nitro-reduction of MISO occurs,
since both ofthese mechanisms could give
rise to new products.
A Electron donating species -toxicity via electron shunting
e-
R-NO2 R-NO2- -R-NO =-R-NHOH--R- NH2
02~~
O2 °2 (> R-SH--Reduced
Torget ~ ~~~toxicity Aerobic toxicity Target
Hypoxic cell toxicity
FIG. 8.-Model indicating how the toxicity
of MISO may be mediated through drug
metabolism and the role which sulphydryls
and 02 may play in this process. Site A
represents the electron-donating species in
the cell ("nitro-reductases") which feed
electrons into the pathway via which
MISO is reduced to its corresponding amino
form. Toxicity may result here from the
shunting of electrons away from energy-
producing metabolic pathways in the cell.
Site B is where the inhibitory effects of 02
on the metabolism and toxicity of MISO
are manifested. Site C represents a short-
lived toxic intermediate which may react
with a critical cell target leading to cell
death. Alternatively this intermediate may
be scavenged by intracellular or added
sulphydryls, represented by Site D in this
diagram, in reducing the toxicity ofMISO.
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To provide some framework within
which to discuss these observations, a
possible model for the metabolism-medi-
ated toxicity ofMISO and the roles which
sulphydryls and 02 may play is shown in
Fig. 8. Site A represents the electron-
donating species in the cell or nitro-
reductase. The enhanced metabolism when
cells are incubated with MISO in the
presence ofASC or MEA could be a conse-
quence of a direct effect on the electron-
donating capacities or nitro-reductase
activities of the cell. No direct inter-
actions under anoxic conditions between
ASC and MIS could be detected, in a
purely chemical system (data not shown).
However, ASC has been previously shown
to increase liver microsomal drug metabo-
lism (e.g. NADPH-cytochrome c reductase,
NADPH-cytochrome P-450 reductase;
Zannoni & Sato, 1975). The chemical
reduction of MISO with Fe2+ ions and
MEA reported by Bahnemann et al. (1978)
could bereproduced here (data not shown).
Further work is being done with this to
compare the chemically produced metabo-
lites with those seen in cell-extract
chromatograms (Figs 3C and G). The
differences in the sensitivities ofHeLa and
CHO cells (Figs 1 and 2) have been shown
to be associated with differences in rates
of drug metabolism (Taylor & Rauth,
1978) and also may reflect differences at
Site A.
Site B is where the inhibitory effects of
02 on the toxicity and metabolism of
MISO noted in the split-dose experiments
(Figs 5 and 7) are likely to occur. The
toxicity of MISO at very high concentra-
tions under aerobic conditions (Fig. 4)
where no drug breakdown occurs may be
mediated by the formation of excessive
levels of peroxides and radicals from the
oxidation of the nitro-radical back to the
parent compound (Mason, 1979).
Site C represents a short-lived toxic
intermediate which is formed under
hypoxic conditions and leads to cell death
via reaction with some critical target,
presumably DNA (Knight et al., 1979;
Palcic & Skarsgard, 1978). Alternatively,
this intermediate may be scavenged by
intracellular sulphydryls represented by
Site D in Fig. 8. A toxicity mechanism
involving an early depletion ofsulphydryls
may give rise to the shoulder-region
differences seen in Fig. 1. The decrease in
toxicity seen with MEA and GSH may be
due to a longer time being required for
R-SH depletion, whereas the increase in
toxicity observed with ASC may be asso-
ciated with a faster rate of R-SH deple-
tion. Support for such a mechanism comes
from the observations of Varnes et al.
(1980) that MISO catalyses the depletion
of intracellular non-protein thiols (NPSH)
in hypoxic Ebrlich ascites, V79 and CHO
cells. They also found the rate of NPSH
depletion to be increased by 10mM ASC.
Consistent with this mechanism is the re-
appearance of a shoulder region when
MEA is added at the 10-2 survival level
(Fig. 6). This mechanism could account
for the appearance of new peaks in the
chromatograms when cells are incubated
with MISO in combination with GSH or
MEA (Fig. 3) and for the rapid appearance
of a similar metabolite when MEA is
added at the 10-2 survival level (Fig. 7) if
stable thiol adducts were formed. Pre-
liminary attempts to identify a thiol
adduct in the chromatographic distribu-
tions for (MISO +MEA)-treated cells
were inconclusive.
It is unlikely that the modifying effects
of ASC, GSH and MEA on the toxicity of
MISO can be accounted for entirely by
either an R-SH-depletion mechanism or
changes in the rate of drug reduction to
more reactive intermediates since both of
these modes of operation are consistent
with the results presented here and else-
where. Furthermore a dual mode of action
may account for some of the variability in
the in vitro data. For example, the differing
effects on the shape ofsurvival curves seen
forcellstreatedwithASC +MISO (shoulder
effect: Fig. 1; slope effect (this paper)
and Fig. 3 in Koch et al. (1979)), may be
the result ofdifferences in the predominant
mode of action in these situations. If ASC
were operating at Site A in Fig. 8 and an
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increased rate of formation of toxic drug
metabolite(s) resulted, the rate of cell
killing might be affected. This might be
expressed as a change in slope of the
resulting survival curve. In contrast, a
R-SH-depletion mechanism could account
for a reduction in the shoulder region of
survival curves.
Variations in tissue and individual
nitro-reductase activities, ASC levels and
R-SH levels could influence the human
pharmacology of MISO and similar nitro-
gorup-containing compounds currently
being investigated as hypoxic cell radio-
sensitizers and cytotoxic agents. Further
work is necessary to characterize what
role these factors play in the in vivo situa-
tion. Ultimately, an understanding ofsuch
factors should aid in the implementation
of radiosensitizers to achieve the best
possible therapeutic effect.
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